HRO350
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HRO350, covering 2025-03-25 to 2025-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study). [Phase 2]